The Oxford/AstraZeneca Vaccine Efficacy Data: We’re going to have to wait and collect more data to be able to say
anything about these, for any of the vaccines. But the data today make
me quite curious about the coming J&J data. That’s another
adenovirus vector, as mentioned, and there’s at least a possibility that
we will then have a good head-to-head comparison between mRNA vaccines
and adenovirus vector vaccines for the same pathogen. That’s a pretty
strange situation – when did we ever have multiple simultaneous vaccines
for the same disease? And there’s the Novavax recombinant protein one
coming after that. No, this is a unique situation. Let’s hope it stays
unique!
